Tag Archives: psilocybin clinical trials

Psilocybin Research in Canada 2026: What New Clinical Trials and Policy Signals Mean for Magic Mushroom Users

Canada’s psilocybin landscape is shifting fast in 2026 — from new clinical research partnerships to evolving policy signals. Here’s what the latest developments actually mean for people who use, buy, or microdose magic mushrooms in Canada.

Psilocybin Research in Canada: What the Latest Clinical Investment Means for Magic Mushroom Users

A $2-million investment in psychedelic medicine at St. Joseph’s Healthcare Hamilton is accelerating psilocybin research in Canada. We break down what this means for therapeutic access, product quality, and the future of the magic mushroom community.